首页> 外文OA文献 >The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

【2h】

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

机译：多奈哌齐，加兰他敏，卡巴拉汀和美金刚治疗阿尔茨海默氏病的有效性和成本效益（技术鉴定报告编号111）：系统评价和经济模型。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Alzheimer’s disease (AD) is the most commonly occurring form of dementia. It is predominantly a disease of later life, affecting 5% of those over 65 in the UK.

机译：阿尔茨海默氏病（AD）是痴呆症最常见的形式。它主要是晚年生活的疾病，影响了英国65岁以上人群的5％。

著录项

作者
Bond, M; Rogers, G; Peters, J; Anderson, R; Hoyle, M; Miners, A; Moxham, T; Davis, S; Thokala, P; Wailoo, A; Jeffreys, M; Hyde, C;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of technology appraisal no. 111): A systematic review and Economic model [J] . BondM., RogersG., PetersJ., Health technology assessment: HTA . 2012,第21期

机译：多奈哌齐，加兰他敏，卡巴拉汀和美金刚治疗阿尔茨海默氏病的有效性和成本效益（技术鉴定第111号复审）：系统评价和经济模型
2. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of TA111): a systematic review and economic model [J] . Health technology assessment: HTA . 2012,第21期

机译：多奈哌齐，加兰他敏，卡巴拉汀和美金刚治疗阿尔茨海默氏病的有效性和成本效益（TA111综述）：系统评价和经济模型
3. The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No. 150 and part review of technology appraisal No. 118): a systematic review and economic model [J] . Health technology assessment: HTA . 2013,第14期

机译：一线化疗后西妥昔单抗（单药或联合化疗），贝伐单抗（与非奥沙利铂化疗联合）和帕尼单抗（单药）治疗转移性结直肠癌的临床疗效和成本效益（技术评估编号第150号技术评估和第118号技术评估的部分复审：系统复审和经济模型
4. Techno-Economic Analysis of Integrated Wastewater Treatment and Biomass Energy Generation Technologies: A Systematic Literature Review [C] . A. Elizondo-Noriega, N. Tiruvengadam, C. Fedler, Institute of Industrial and Systems Engineers Annual Conference and Expo . 2021

机译：综合废水处理和生物量能源技术的技术经济分析：系统文献综述
5. Cost-effectiveness of intensified interventions to control healthcare-associated MRSA infections -- A systematic literature review. [D] . Talluri, Krishna C. 2013

机译：加强干预措施以控制与医疗保健相关的MRSA感染的成本效益-系统的文献综述。
6. The effectiveness and cost-effectiveness of donepezil galantamine rivastigmine and memantine for the treatment of Alzheimers disease (review of Technology Appraisal No. 111): a systematic review and economic model. [O] . M Bond, G Rogers, J Peters, -1

机译：阿尔茨海默氏病的治疗的有效性和多奈哌齐加兰他敏卡巴拉汀的成本效益及美金刚（估价111号审查技术）的系统评价和经济模式。
7. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model. [O] . Crathorne, L., Huxley, N., Haasova, M., 2016

机译：红细胞生成刺激剂（epoetin和darbepoetin）治疗癌症治疗诱导的贫血的有效性和成本效益（包括技术评估第142号评论）：系统评价和经济模型。

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

摘要

著录项

相似文献

相关主题

期刊订阅